Status:
COMPLETED
Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3
Lead Sponsor:
University of Freiburg
Collaborating Sponsors:
University Heart Center Freiburg - Bad Krozingen
Heart and Diabetes Center North Rhine-Westphalia
Conditions:
Ventricular Assist Device
Psychosocial Factors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The number of patients suffering from end-stage heart disease challenges healthcare services in the western world, where an estimated 1-2% of the population suffer from this chronic condition. Ventric...
Detailed Description
The number of patients suffering from end-stage heart disease challenges healthcare services in the western world, where an estimated 1-2% of the population suffer from this chronic condition. Ventric...
Eligibility Criteria
Inclusion
- Stable postoperative condition
- Outpatient treatment at the respective heart center
- 18 years and older
- No contraindications (e.g. Cognitive, Language)
- Signed Informed Consent
Exclusion
- Not an outpatient at the respective heart center
- Underage
- Contraindications (e.g. Cognitive, Language)
- No signed Informed Consent
- Participation in other behavior-related studies
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04526964
Start Date
September 7 2020
End Date
January 15 2023
Last Update
May 10 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University Heart Center Freiburg • Bad Krozingen
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79110
2
Heart and Diabetes Center NRW, Bad Oeynhausen
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545
3
Leipzig Heart Center
Leipzig, Saxony, Germany, 04289
4
German Heart Center Berlin
Berlin, Germany, 13353